18 June 2013
Keywords: barr, labs, raises, 2nd-qtr, earnings, forecast, generics
Article | 20 January 2003
US generics firm Barr Laboratories has said that, based on preliminaryestimates, it expects earnings per share, assuming dilution, for the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 January 2003
13 January 2003
© 2013 thepharmaletter.com